NEW YORK (
CHANGE IN RATINGS
(AEO - Get Report) was upgraded at Wedbush from Neutral to Outperform. $22 price target. Positive store checks suggest that higher sales and margins are around the corner, Wedbush said.
(AH) was downgraded at UBS to Neutral from Hold. $11 price target. Possibly more issues lurking around the corner, UBS said.
(ALR - Get Report) was upgraded at Leerink Swann to Outperform from Market Perform. $28-$30 valuation range. Attractive upside potential, Leerink Swann said.
Abercrombie & Fitch
(ANF - Get Report)
was upgraded to Buy from Neutral at UBS. $66 price target. Trend stabilization and favorable risk/reward, UBS said.
was upgraded at Piper Jaffray from Neutral to Overweight. $32 price target. Company is posting higher sales growth, Piper Jaffray said.
was upgraded at Mizuho from Neutral to Buy. $35 price target. Business fundamentals are improving, Mizuho said.
(COST - Get Report)
was downgraded at Deutsche Bank to Hold. Valuation call, based on an $89 price target, Deutsche Bank said.
was initiated with a Buy rating at Canaccord Genuity. $32 price target. Company has a broad product portfolio that addresses a big market opportunity, Canaccord said.
was upgraded at Morgan Stanley from Underweight to Equal-Weight. Visibility is improving and the Pall purchase can drive long-term growth, Morgan Stanley said.
(HOLX - Get Report)
was downgraded at Dougherty to Neutral. $20 price target. GPRO acquisition is unimpressive, Dougherty said.
was downgraded at Auriga USA from Buy to Hold. Valuation call, based on a $98 price target, Auriga USA said.
was initiated with a Hold rating at Keybanc. Company lacks near-term catalysts, Keybanc said.
was initiated with a Neutral rating at Goldman Sachs. Valuation call, based on a $23 price target.
Vantiv was initiated with a Buy rating at Deutsche Bank. $26 price target. New merchant wins are driving organic growth, Deutsche Bank said.
was upgraded at Credit Suisse from Neutral to Outperform. $27 price target. Estimates also boosted, as management is turning the business around, Credit Suisse said.
STOCK COMMENTS / EPS CHANGES
Bed Bath & Beyond
numbers raised at Oppenheimer. Shares are now seen reaching $84. Estimates were also raised on sales and margin momentum, Oppenheimer said. Outperform rating.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts